21:46 , Jan 17, 2019 |  BC Innovations  |  Finance

Public funding highlights

Public funding highlights Selected developments and initiatives in 4Q18 from major sources of public funding including National Institutes of Health (NIH), the U.K.’s Medical Research Council (MRC), the Innovative Medicines Initiative (IMI), the Canadian Institutes...
21:20 , Dec 14, 2018 |  BC Week In Review  |  Financial News

Allen Insitute's immunology division launches with $125M, Lilly vet and five partners

The Allen Institute expects its latest research endeavor to generate knowledge about molecular drivers of immune-related diseases, paving the way for new diagnostics and therapies. The Allen Institute for Immunology launched on Dec. 12 with...
00:23 , Dec 13, 2018 |  BC Extra  |  Preclinical News

Allen Institute's immunology division launches with $125M, Lilly vet and five partners

The Allen Institute expects its latest research endeavor to generate knowledge about molecular drivers of immune-related diseases, paving the way for new diagnostics and therapies. The Allen Institute for Immunology launched Wednesday with $125 million...
00:05 , Dec 12, 2018 |  BC Extra  |  Company News

Management tracks: Merck creates new commercial roles to follow Schechter's exit

Merck & Co. Inc. (NYSE:MRK) said President of Global Human Health Adam Schechter will step down at the end of the year. The company will restructure his former position into two new roles effective Jan....
13:10 , Dec 4, 2018 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Prostate cancer Cell culture and mouse studies suggest inhibiting Hsp70 could help treat prostate cancer resistant to Xtandi enzalutamide and/or Zytiga abiraterone acetate. In human prostate cancer cell lines, high Hsp70 levels were associated...
18:10 , Nov 9, 2018 |  BC Week In Review  |  Company News

Genentech seeks to block JHL from using trade secrets

Genentech Inc. is asking a federal court to block JHL Biotech Inc. (Zhubei, Taiwan) from making and selling products the company claims benefited from its proprietary information, following the indictment of three former Genentech employees...
00:40 , Nov 8, 2018 |  BC Extra  |  Company News

Genentech seeks to block JHL from using trade secrets

Genentech Inc. is asking a federal court to block JHL Biotech Inc. (Zhubei, Taiwan) from making and selling products the company claims benefited from its proprietary information, following the indictment of three former Genentech employees...
20:04 , Nov 2, 2018 |  BC Week In Review  |  Financial News

Twist raises $70M in NASDAQ IPO

Twist Bioscience Corp. (NASDAQ:TWST) raised $70 million in an IPO of 5 million shares at $14 on Oct. 31. The price values the DNA synthesis company at $372.5 million. Twist had proposed to sell 5...
00:06 , Sep 28, 2018 |  BC Innovations  |  Emerging Company Profile

GDF11 against aging

Harvard University spinout Elevian Inc. is developing a regenerative platform around GDF11 to treat age-related diseases, including Alzheimer's disease. The company, which emerged from stealth on Sept. 6, aims to modulate the protein’s pathway with...
18:56 , Aug 31, 2018 |  BC Week In Review  |  Company News

Gritstone files for IPO, forges deal with bluebird

Gritstone Oncology Inc. (Emeryville, Calif.) filed for an IPO on NASDAQ and announced a deal with bluebird bio Inc. (NASDAQ:BLUE) to develop cell therapies using natural T cell receptors (TCRs) against tumor-specific targets. Gritstone filed...